CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00179-06v1
14/2/204    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steptoe, A.
Right arrow Articles by Henderson, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steptoe, A.
Right arrow Articles by Henderson, B.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, February 2007, p. 204-207, Vol. 14, No. 2
1071-412X/07/$08.00+0     doi:10.1128/CVI.00179-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Protective Effect of Human Heat Shock Protein 60 Suggested by Its Association with Decreased Seropositivity to Pathogens{triangledown}

A. Steptoe,1 A. Shamaei-Tousi,2 Å. Gylfe,3 L. Bailey,3 S. Bergström,3 A. R. Coates,4 and B. Henderson2*

Department of Epidemiology and Public Health,1 Division of Microbial Diseases, UCL Eastman Dental Institute, University College London, London, United Kingdom,2 Department of Molecular Biology, Umeå University, Umeå, Sweden,3 Medical Microbiology, Department of Cellular and Molecular Medicine, St. George's, University of London, London, United Kingdom4

Received 17 May 2006/ Returned for modification 1 September 2006/ Accepted 7 December 2006

The presence of heat shock protein 60 (Hsp60) in human plasma has been linked with cardiovascular disease (CVD). In this study, the examination of the relationship between Hsp60 in plasma and seropositivity for three microbial agents, which are thought to be risk factors for CVD, surprisingly revealed a negative association between Hsp60 and seropositivity, suggesting a protective effect of this circulating stress protein.


* Corresponding author. Mailing address: Division of Microbial Diseases, UCL Eastman Dental Institute, University College London, 256 Gray's Inn Road, London WC1X, United Kingdom. Phone: 44 20 7915 1190. E-mail: b.henderson{at}eastman.ucl.ac.uk.

{triangledown} Published ahead of print on 3 January 2007.


Clinical and Vaccine Immunology, February 2007, p. 204-207, Vol. 14, No. 2
1071-412X/07/$08.00+0     doi:10.1128/CVI.00179-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.